# High Dose SBRT for Abdominal-Pelvic Lymph Nodal Lesions in Oligometastatic Patients

> **NCT02570399** · NA · UNKNOWN · sponsor: **Istituto Clinico Humanitas** · enrollment: 55 (actual)

## Conditions studied

- Lymph Node Cancer Metastatic

## Interventions

- **RADIATION:** Oligometastatic patients with abdominal-pelvic lymph nodes

## Key facts

- **NCT ID:** NCT02570399
- **Lead sponsor:** Istituto Clinico Humanitas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02-26
- **Primary completion:** 2019-03-26
- **Final completion:** 2022-12
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2021-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02570399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02570399, "High Dose SBRT for Abdominal-Pelvic Lymph Nodal Lesions in Oligometastatic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02570399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*